Oxford Chemistry has an outstanding track record in translating fundamental research to effect real-world change.
Commercialisation through the formation of spinout companies is an important way our research can bring societal and economic benefit, and the University of Oxford is the leading academic institution in the UK for generating spinout companies (Spotlight on Spinouts 2023).
From our ground-breaking work on the lithium-ion battery, to rapid DNA sequencing and a pioneering blood glucose sensor for diabetes, many of these spinout companies started in our Department. Indeed, two of the top five spinout investees in the UK in 2022 emerged from Oxford Chemistry: Osler Diagnostics and OMass Therapeutics.
The University has also produced the highest number of tech unicorn founders across Europe, including Chemistry spinout Oxford Nanopore, valued at £3.4 billion in 2021.